Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01645
|
|||||
| Drug Name |
Cephaeline
|
|||||
| Synonyms |
Cephaeline; Cephaelin; 483-17-0; 7',10,11-Trimethoxyemetan-6'-ol; UNII-QA971541A1; Desmethylemetine; QA971541A1; Dihydropsychotrine; Cepheline; GNF-Pf-307; (1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol; NSC32944; Cephaelinel; (-)-Cephaeline; EINECS 207-591-6; Prestwick2_000428; Prestwick3_000428; Prestwick1_000428; Prestwick0_000428; AC1L9CF2; BSPBio_000416; SCHEMBL181711; SPBio_002355; CHEMBL255708
|
|||||
| Indication | Accidental poisoning [ICD11: PB20-PB29] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C28H38N2O4
|
|||||
| Canonical SMILES |
CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=CC(=C(C=C5CCN4)O)OC)OC)OC
|
|||||
| InChI |
InChI=1S/C28H38N2O4/c1-5-17-16-30-9-7-19-13-27(33-3)28(34-4)15-22(19)24(30)11-20(17)10-23-21-14-26(32-2)25(31)12-18(21)6-8-29-23/h12-15,17,20,23-24,29,31H,5-11,16H2,1-4H3/t17-,20-,23+,24-/m0/s1
|
|||||
| InChIKey |
DTGZHCFJNDAHEN-OZEXIGSWSA-N
|
|||||
| CAS Number |
CAS 483-17-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 466.6 | Topological Polar Surface Area | 63.2 | ||
| Heavy Atom Count | 34 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
4.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:3533
|
|||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Wikipedia: Cephaeline | |||||
| 2 | Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors. Bioorg Med Chem. 2012 Sep 15;20(18):5388-95. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.